Pfizer's Revenue by Segment
In fiscal year 2024, Pfizer's revenue by segment (products & services) are as follows:
- Biopharma Segment: $8.39 B
Learn more about Pfizer’s Revenue by Geography
Check out competitors to Pfizer in a side-by-side comparison.
Explore additional financial metrics for Pfizer.
| Biopharma Segment | 8537000000 |
|---|
| Biopharma Segment | 7582000000 |
|---|
| Biopharma Segment | 8388000000 |
|---|
The above chart shows Pfizer's revenue percentage share by segment (products and services).
In fiscal year 2022, Pfizer's revenue by segment is as follows:
- Biopharma Segment generated $8.54 B in revenue, representing 100% of its total revenue.
The biggest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.
The smallest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.
The above chart shows Pfizer's revenue percentage share by segment (products and services).
In fiscal year 2023, Pfizer's revenue by segment is as follows:
- Biopharma Segment generated $7.58 B in revenue, representing 100% of its total revenue.
The biggest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.
The smallest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.
The above chart shows Pfizer's revenue percentage share by segment (products and services).
In fiscal year 2024, Pfizer's revenue by segment is as follows:
- Biopharma Segment generated $8.39 B in revenue, representing 100% of its total revenue.
The biggest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.
The smallest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2022 | 2023 | 2024 |
|---|---|---|---|
| Biopharma Segment | 100% | 100% | 100% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of Pfizer.
In fiscal year 2024, the Biopharma Segment generated the most revenue ($8.39 B), and the Biopharma Segment generated the least revenue ($8.39 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
